Clinical Trial Update: A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the bevacizumab biosimilar SB-8 to Avastin in adults with advanced non-squamous non-small cell lung cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• SB-8 (Bevacizumab)

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Lung Cancer, Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-12-16